閎創科技股份有限公司
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
Antibody-Free Rare Cell Isolation and Screening Chip and System for Prenatal Testing Services
The content above was translated by Ai
Founded Year
2019
Unified Business No.
85061267
Status
Closed
Number of Employees
0
Total Paid-in
Capital
200,000 (NT$)
Location of Company
Taiwan
, Tainan City
Website
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Exclusively innovative antibody-free rare cell isolation and screening chips and systems are applied to prenatal testing services, utilizing physical light-induced non-uniform electric field technology to isolate and screen rare cells. By combining innovative microwave dielectric algorithms with microwave chips and intelligent platform systems, the technology accurately provides next-generation DNA sequencing (NGS) without the need for mycoplasma replication, thereby reducing the occurrence of errors, enabling early detection of fetal conditions, and allowing for early treatment.
The content above was translated by Ai
